1. Metabolic Enzyme/Protease Immunology/Inflammation
  2. Epoxide Hydrolase FLAP
  3. sEH/FLAP-IN-2

sEH/FLAP-IN-2 是一种选择性 sEH (IC50 = 12.6 nM)/FLAP 双重抑制剂。sEH/FLAP-IN-2 可显著减少 5-LOX/FLAP 和 sEH 衍生的脂质体,从而促进脂质体的重新分布。sEH/FLAP-IN-2 可用于腹膜炎的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

sEH/FLAP-IN-2

sEH/FLAP-IN-2 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

sEH/FLAP-IN-2 is a selective sEH (IC50 = 12.6 nM)/FLAP dual inhibitor. sEH/FLAP-IN-2 highlights the reduction of 5-LOX/FLAP- and sEH-derived LMs, resulting in a favourable redistribution of LMs. sEH/FLAP-IN-2 can be used for the study of peritonitis[1].

体外研究
(In Vitro)

sEH/FLAP-IN-2 (Compound 6) 对 5-LOX 无显著抑制活性,IC50 值 >10 μM[1]
在人中性粒细胞中,sEH/FLAP-IN-2 (10 μM,15 分钟) 在 FLAP 依赖性系统中,在无外源性花生四烯酸 (AA) 的情况下,显著抑制 5-LOX 产物 (LTB4、反式-LTB4 和 5-HETE) 的生成,残余活性为 35.7%;在存在外源性 AA 的情况下,其抑制活性减弱 (IC50 > 10 μM)[1]
sEH/FLAP-IN-2 (0.1-10 μM,16 分钟) 对 COX-1、COX-2 和 mPGES-1 的活性无显著影响[1]
sEH/FLAP-IN-2 (0.1-10 μM,120 分钟) 浓度依赖性地抑制 5-LOX/FLAP 衍生的介质 (如 LTB4 和 LTC4) ,尤其是在 M1-MDM 中;同时,它增加 COX 衍生的前列腺素 (如 PGE2 和 PGD2),但不影响 SPM (如 RvD5) 的水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

sEH/FLAP-IN-2 (Compound 6) (10 mg/kg,腹腔注射,一次) 通过双重抑制 FLAP 和 sEH,有效调节小鼠腹膜炎模型中的脂质介质谱,使脂质介质谱从促炎状态 (LTs 和 DHETs) 转变为抗炎状态 (EETs)[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: CD-1 mice (33-39 g, 8 weeks old) were given an acute inflammatory response via intraperitoneal injection of Zymosan (HY-159069) (1 mg/mouse)[1].
Dosage: 10 mg/kg
Administration: I.p., once, 30 mins before zymosan
Result: Significantly reduced zymosan-induced levels of pro-inflammatory mediators, including LTB4, 5-HETE, and LTE4.
Increased levels of anti-inflammatory EETs (particularly 11,12-EET and 14,15-EET) while decreasing levels of pro-inflammatory DHETs (such as 11,12-DHET), resulting in an elevated EET/DHET ratio.
PGE2 levels were significantly reduced, but TXB2 was unaffected.
分子量

447.57

Formula

C26H33N5O2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
sEH/FLAP-IN-2
目录号:
HY-179441
需求量: